Stock NUTEX NUTEX INVESTMENTS PUBLIC LIMITED COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials NUTEX Investments Public Limited Company

Equities

NUTEX

HU0000207634

Pharmaceuticals

End-of-day quote Budapest S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
14.35 HUF +0.70% Intraday chart for NUTEX Investments Public Limited Company +0.35% +1.06%
2023 NUTEX Investments Public Limited Company Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 NUTEX Investments Public Limited Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022
Capitalization 1 1,780 2,185 2,207 2,133
Enterprise Value (EV) 1 1,047 -601.6 -2,143 -2,189
P/E ratio -52.6 x 66.4 x 151 x 16.3 x
Yield - - - -
Capitalization / Revenue 2,374 x 4,856 x 4,904 x 4,740 x
EV / Revenue 1,396 x -1,337 x -4,762 x -4,864 x
EV / EBITDA -110 x 32.9 x 171 x 139 x
EV / FCF - -2,341,480 x 182,131,746 x 12,749,222 x
FCF Yield - -0% 0% 0%
Price to Book 0.8 x 0.61 x 0.43 x 0.4 x
Nbr of stocks (in thousands) 37,166 91,431 148,111 148,111
Reference price 2 47.90 23.90 14.90 14.40
Announcement Date 3/19/21 3/19/21 4/19/22 4/27/23
1HUF in Million2HUF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 0.75 0.45 0.45 0.45
EBITDA 1 -9.548 -18.27 -12.56 -15.79
EBIT 1 -9.647 -18.56 -12.91 -15.97
Operating Margin -1,286.27% -4,124% -2,868% -3,548%
Earnings before Tax (EBT) 1 -7.717 27.32 13.29 138.7
Net income 1 -8.013 26.09 12.69 133.5
Net margin -1,068.4% 5,797.11% 2,819.33% 29,672.44%
EPS 2 -0.9100 0.3600 0.0985 0.8854
Free Cash Flow - 256.9 -11.77 -171.7
FCF margin - 57,097.47% -2,614.61% -38,151.28%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - 984.93% - -
Dividend per Share - - - -
Announcement Date 3/19/21 3/19/21 4/19/22 4/27/23
1HUF in Million2HUF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 - - - -
Net Cash position 1 733 2,787 4,350 4,322
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 257 -11.8 -172
ROE (net income / shareholders' equity) - 0.96% 0.29% 2.55%
ROA (Net income/ Total Assets) - -0.43% -0.18% -0.19%
Assets 1 - -6,111 -6,906 -70,166
Book Value Per Share 2 59.90 39.40 34.90 35.80
Cash Flow per Share 2 24.10 30.50 26.30 18.80
Capex 1 0.1 0.58 0.43 -
Capex / Sales 13.2% 127.78% 95.33% -
Announcement Date 3/19/21 3/19/21 4/19/22 4/27/23
1HUF in Million2HUF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
NUTEX INVESTMENTS PUBLIC LIMITED COMPANY Stock NUTEX Investments Public Limited Company
+1.06% 5.78M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NUTEX Stock
  4. Financials NUTEX Investments Public Limited Company